JOHNSON & JOHNSON is 508.5x more valuable than COLLEGIUM PHARMACEUTICAL, INC by market capitalization ($573.98 B vs $1.13 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | COLL | JNJ |
|---|---|---|
| Market cap | $1.13 B | $573.98 B |
| US-listed rank | #2551 | #20 |
| Revenue (latest FY) | $780.57M | $94.19B |
| Net income (latest FY) | $63.00M | $26.80B |
| Net margin | 8.1% | 28.5% |
| P/E (trailing FY) | 17.9 | 21.4 |
| SEC filings | 849 | 984 |
JOHNSON & JOHNSON is 508.5x more valuable than COLLEGIUM PHARMACEUTICAL, INC by market capitalization ($573.98 B vs $1.13 B).
In their latest fiscal years, COLLEGIUM PHARMACEUTICAL, INC reported $780.57M in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: COLLEGIUM PHARMACEUTICAL, INC and JOHNSON & JOHNSON, or browse the full rankings.